Farxiga vs. Ozempic

See how Farxiga and Ozempic compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Farxiga is a once-daily pill, while Ozempic is a once-weekly injection, so the day-to-day routine is very different.

  • Both drugs protect the heart and kidneys in type 2 diabetes, but Ozempic tends to cause more weight loss and Farxiga carries more genital infection risk.

  • Farxiga has a lower typical monthly list price than Ozempic before insurance.

Farxiga vs. Ozempic Drug Summary

Farxiga

Farxiga (dapagliflozin) is an SGLT2 inhibitor that lowers blood sugar by causing the kidneys to remove extra glucose through urine. It's approved for type 2 diabetes, heart failure, and chronic kidney disease, and is taken as an oral tablet once a day.

Ozempic

Ozempic (semaglutide) is a GLP-1 receptor agonist that controls blood sugar by mimicking a gut hormone that boosts insulin release and slows digestion. It's approved for type 2 diabetes and to reduce cardiovascular and kidney risks, and is given as a once-weekly injection.

Farxiga vs. Ozempic Side Effects

Farxiga

Most common
female genital mycotic infections (6.9%)
nasopharyngitis (6.3%)
urinary tract infections (4.3%)
back pain (4.2%)

Ozempic

Most common
nausea (up to 20.3%)
vomiting (up to 9.2%)
diarrhea (up to 8.8%)
abdominal pain (up to 7.3%)

Farxiga vs. Ozempic Dosage

Farxiga

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg once daily At the start
Maximum dose 5 mg once daily Same as starting
Dose changes None Fixed dose

Ozempic

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.25 mg once weekly Weeks 1-4
Maximum dose 0.5 mg once weekly Week 5 onward
Dose changes 1 increase Every 4 weeks

Farxiga vs. Ozempic Indications

Farxiga

Farxiga is FDA-approved to lower blood sugar in adults and children 10 and older with type 2 diabetes. It also has approvals for heart failure, including in patients with preserved ejection fraction, and for slowing chronic kidney disease.

  • Type 2 diabetes blood sugar control (adults and children 10+)

  • Heart failure to reduce cardiovascular death and hospitalization

  • Reduce heart failure hospitalization risk in diabetes with CV risk factors

  • Slow kidney function decline in chronic kidney disease

Ozempic

Ozempic is FDA-approved to control blood sugar in adults with type 2 diabetes alongside diet and exercise. It's also approved to lower the risk of major cardiovascular events in patients with known heart disease and to slow kidney damage progression. Some clinicians prescribe it off-label for weight loss, though that use is not FDA-approved under this brand.

  • Type 2 diabetes blood sugar control in adults

  • Reduce risk of heart attack, stroke, and death in known heart disease

  • Slow kidney damage progression in chronic kidney disease

  • Off-label: weight loss in people without diabetes

Farxiga vs. Ozempic Pros and Cons

Farxiga

Farxiga is a well-tolerated oral option with broad approvals spanning diabetes, heart failure, and kidney disease. Its main risks involve genital and urinary infections rather than the digestive issues common with GLP-1 drugs like Ozempic.

Pros

  • Oral tablet, no injection needed

  • Approved for heart failure with reduced and preserved ejection fraction

  • Approved for children 10 and older with type 2 diabetes

  • Roughly $400 to $785 per month before insurance, less than Ozempic

Cons

  • Carries risk of genital yeast infections and urinary tract infections

  • Rare but serious risk of Fournier's gangrene

  • Not recommended for glycemic control at low kidney function (eGFR under 45)

  • Does not produce the substantial weight loss seen with GLP-1 drugs

Ozempic

Ozempic's weekly injection and strong weight-loss effect make it appealing for many people with type 2 diabetes, but it carries a boxed warning and common digestive side effects. It's also considerably more expensive than Farxiga without insurance coverage.

Pros

  • Only needs to be taken once a week, not daily

  • Associated with significant weight loss in clinical trials

  • Approved to reduce major cardiovascular events in known heart disease

  • Also approved to slow kidney disease progression in type 2 diabetes

Cons

  • Carries a boxed warning for thyroid C-cell tumor risk seen in animal studies

  • Digestive side effects like nausea and vomiting are common

  • Requires a weekly injection rather than a pill

  • Roughly $935 to $1,043 per month before insurance, more than Farxiga

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.